Zotide 750mcg Injection is a prescription medicine containing teriparatide, a synthetic form of human parathyroid hormone, used to treat osteoporosis in adults. It is commonly prescribed for postmenopausal women, men with primary or hypogonadal osteoporosis, and patients who develop bone loss due to long-term corticosteroid therapy. Osteoporosis weakens bones and increases fracture risk, especially in the spine and hip, making early and effective treatment essential.
Zotide 750mcg Injection works by stimulating new bone formation rather than just slowing bone loss. It activates osteoblasts, the cells responsible for building bone, helping improve bone mineral density and overall bone strength. The injection is given once daily under the skin, usually in the thigh or abdomen, and treatment is limited to a maximum of two years under medical supervision. Common side effects may include dizziness, nausea, headache, joint or leg pain, and mild injection site reactions. Regular monitoring by a doctor ensures safe and effective results while reducing the risk of complications.
Zotide 750mcg Injection works by helping the body build new bone. It contains teriparatide, a man-made form of a natural hormone called parathyroid hormone (PTH). When given in small daily doses, it activates special bone-building cells called osteoblasts. This helps increase bone strength and thickness, making bones less likely to break. Unlike some other medicines that only slow down bone loss, Zotide actually helps create new bone. Because of its powerful effect, treatment is usually limited to two years.
Side Effects of Zotide 750mcg Injection
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
The usual dose of Zotide 750mcg is one injection daily, given under the skin in the thigh or abdomen. Change the injection spot each day to avoid skin problems. Treatment should not last more than 2 years in a lifetime, and after that, your doctor may switch you to another bone-strengthening medicine. If you miss a dose, take it the same day when you remember, but never take two doses on the same day.
It is unknown if teriparatide passes into breast milk. Use only if prescribed and deemed necessary by a healthcare provider.
Alcohol may interfere with bone health and increase the risk of falls or fractures. Limit or avoid alcohol consumption while on this medication.
Zotide 750mcg may rarely cause breathing problems; seek medical help if you experience chest pain, cough, or shortness of breath.
Zotide may cause dizziness or light-headedness, especially shortly after injection. Avoid driving or operating heavy machinery until you know how the medicine affects you.
Zotide should not be used by pregnant women unless clearly needed. Discuss with your doctor if you are planning to become pregnant.
Zotide contains teriparatide, a synthetic form of parathyroid hormone. It stimulates new bone formation by increasing the activity of bone-forming cells (osteoblasts), which strengthens bones and reduces fracture risk.
Zotide is used to treat osteoporosis in postmenopausal women, men at high risk of fractures, and people with osteoporosis caused by long-term use of corticosteroids. It increase bone density and reduce the risk of fractures.
It is given as a subcutaneous injection once daily, usually in the abdomen or thigh. It comes in a prefilled pen for self-injection after proper training.
The maximum recommended duration of treatment is 24 months (2 years) in a patient's lifetime. Your doctor may switch you to another bone-strengthening medication afterward.
No, it is not recommended during pregnancy or breastfeeding. Inform your doctor if you are planning to become pregnant.
It should not be combined with other anabolic bone drugs. However, antiresorptive medications like bisphosphonates may be started after completing Zotide therapy.
You should avoid using Zotide if you have certain medical conditions. These include Paget’s disease of bone, unexplained high alkaline phosphatase (ALP) levels, a history of bone cancer or skeletal metastases, or if you have previously received radiation therapy to the bones. It is also not recommended for patients with severe kidney problems. Always inform your doctor about your medical history before starting this treatment.
| Active ingredient | Teriparatide 750mcg |
| Pharmacologic class | Recombinant Human Parathyroid Hormone (rhPTH 1-34) |
| Medication category | Anabolic (bone-forming) Agent for Osteoporosis |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
